Proton Pump Inhibitors and Incident Clostridioides difficile Infection: Beyond Controversy, Pragmatic Approaches Are Needed.
作者信息
Villafuerte-Gálvez Javier A
机构信息
Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
出版信息
Clin Infect Dis. 2021 Jun 15;72(12):e1090-e1092. doi: 10.1093/cid/ciaa1856.
Abstract
摘要
相似文献
1
Proton Pump Inhibitors and Incident Clostridioides difficile Infection: Beyond Controversy, Pragmatic Approaches Are Needed.质子泵抑制剂与艰难梭菌感染：超越争议，需要务实的方法。
Clin Infect Dis. 2021 Jun 15;72(12):e1090-e1092. doi: 10.1093/cid/ciaa1856.
2
Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection.质子泵抑制剂的使用与社区获得性艰难梭菌感染的风险。
Clin Infect Dis. 2021 Jun 15;72(12):e1084-e1089. doi: 10.1093/cid/ciaa1857.
3
Clostridiodes difficile associated disease risk and proton pump inhibitors in critically ill children.危重症儿童中艰难梭菌相关疾病风险与质子泵抑制剂
Enferm Infecc Microbiol Clin (Engl Ed). 2021 Mar;39(3):160-161. doi: 10.1016/j.eimc.2020.06.004. Epub 2020 Jul 14.
4
Response to Daniell.对丹尼尔的回应。
Am J Gastroenterol. 2014 Jun;109(6):922-3. doi: 10.1038/ajg.2014.91.
5
Clostridium difficile infection: managing the risks.艰难梭菌感染：风险管控
JAAPA. 2012 May;25(5):16. doi: 10.1097/01720610-201205000-00002.
6
Acid suppression and the risk of Clostridium difficile infection.酸抑制与艰难梭菌感染风险
J Pediatr. 2013 Sep;163(3):627-30. doi: 10.1016/j.jpeds.2013.04.047. Epub 2013 Jun 5.
7
Does PPI therapy predispose to Clostridium difficile infection?质子泵抑制剂疗法会增加艰难梭菌感染的易感性吗？
Nat Rev Gastroenterol Hepatol. 2009 Sep;6(9):555-7. doi: 10.1038/nrgastro.2009.128.
8
Response to Abdallah et al.对阿卜杜拉等人的回应
Am J Gastroenterol. 2014 Apr;109(4):602-3. doi: 10.1038/ajg.2013.483.
9
Clostridioides difficile and the Microbiota Early in Life.艰难梭菌与生命早期的微生物组。
J Pediatric Infect Dis Soc. 2021 Nov 17;10(Supplement_3):S3-S7. doi: 10.1093/jpids/piab063.
10
Japanese Clinical Practice Guidelines for Management of Clostridioides (Clostridium) difficile infection.艰难梭菌感染管理的日本临床实践指南。
J Infect Chemother. 2022 Aug;28(8):1045-1083. doi: 10.1016/j.jiac.2021.12.011. Epub 2022 May 24.
本文引用的文献
1
Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection.质子泵抑制剂的使用与社区获得性艰难梭菌感染的风险。
Clin Infect Dis. 2021 Jun 15;72(12):e1084-e1089. doi: 10.1093/cid/ciaa1857.
2
Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors.质子泵抑制剂使用者患 COVID-19 的风险增加。
Am J Gastroenterol. 2020 Oct;115(10):1707-1715. doi: 10.14309/ajg.0000000000000798.
3
Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial.质子泵抑制剂与组胺 2 受体拮抗剂预防应激性溃疡对接受有创机械通气的 ICU 患者院内死亡率的影响：PEPTIC 随机临床试验。
JAMA. 2020 Feb 18;323(7):616-626. doi: 10.1001/jama.2019.22190.
4
The Clinician's Guide to Proton-Pump Inhibitor Discontinuation.质子泵抑制剂停药临床指南
J Clin Gastroenterol. 2019 Sep;53(8):553-559. doi: 10.1097/MCG.0000000000001243.
5
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.基于接受利伐沙班或阿司匹林的患者的大型多年随机试验的质子泵抑制剂安全性。
Gastroenterology. 2019 Sep;157(3):682-691.e2. doi: 10.1053/j.gastro.2019.05.056. Epub 2019 May 29.
6
Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU.重症监护病房有胃肠道出血风险的患者使用泮托拉唑。
N Engl J Med. 2018 Dec 6;379(23):2199-2208. doi: 10.1056/NEJMoa1714919. Epub 2018 Oct 24.
7
Proton pump inhibitors and risk of Clostridium difficile infection: association or causation?质子泵抑制剂与艰难梭菌感染风险：关联还是因果关系？
Curr Opin Gastroenterol. 2018 Jan;34(1):11-18. doi: 10.1097/MOG.0000000000000414.
8
Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction.质子泵抑制剂的长期使用、剂量反应关系与缺血性卒中和心肌梗死的相关性。
J Intern Med. 2018 Mar;283(3):268-281. doi: 10.1111/joim.12698. Epub 2017 Nov 7.
9
Updated meta-analysis of controlled observational studies: proton-pump inhibitors and risk of Clostridium difficile infection.更新的对照观察研究荟萃分析：质子泵抑制剂与艰难梭菌感染的风险。
J Hosp Infect. 2018 Jan;98(1):4-13. doi: 10.1016/j.jhin.2017.08.017. Epub 2017 Aug 24.
10
Complications of Proton Pump Inhibitor Therapy.质子泵抑制剂治疗的并发症。
Gastroenterology. 2017 Jul;153(1):35-48. doi: 10.1053/j.gastro.2017.04.047. Epub 2017 May 19.
Zotero 插件